Mitomycins
DBCAT000710Pharmacologic class
A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. A DrugBank category of 2 drugs. 1 of them is approved.
What you can answer from here — as of August 24, 2016
Which targets do Mitomycins share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account